GeneFAN Biopharma Invites You to Attend the 2025 CSGCT Conference

Genevoyager (Wuhan) Co., Ltd.

Abbreviation: Genevoyager

Booth No.: B17

To drive technological breakthroughs, industrial integration, policy alignment, and international cooperation in China’s cell and gene therapy (CGT) sector, and to propel the Chinese CGT industry to the forefront of global competition, the China Society for Cell and Gene Therapy (CSGCT) Conference was established.

Leveraging its close ties with the American Society of Gene & Cell Therapy (ASGCT), the 2025 CSGCT Annual Meeting will bring together leading scientists, clinical experts, multinational pharmaceutical companies, and overseas investment institutions from around the world. The event will showcase the most cutting-edge scientific advances, technologies, applications, and market access information in the global cell and gene therapy field, while facilitating connections between high-quality collaborative projects and overseas investors seeking investment opportunities. It aims to establish a platform for in-depth exchange and cooperation between China’s cell and gene therapy industry and the global supply chain.

The conference closely addressed the industry’s hotspots, pain points, and bottlenecks, featuring1 Main Forum + 15 High-End Sub-Forums, coveringLatest Advances in Global Gene Therapy, Immune Cell Therapy, In Vivo CAR-T, Adult Stem Cells and Exosomes, iPSC-Derived Cell Therapies, Small Nucleic Acid Drugs, Gene Editing, Oncolytic Viruses, and Tumor Vaccines, as well as CMC and Testing, AI-Driven Drug Discovery, and Investment, Financing, and BD Matchmakingdeep coverage across the entire industry chain.

2025 2nd China Society for Gene and Cell Therapy (CSGCT) Conference

September 12–13, 2025

Zhongguancun National Independent Innovation Demonstration Zone Exhibition and Trading Center [Conference Center]

For more details, scan the QR code to visit the official conference website.